BusinessEconomy Google wins appeal of $20 million US patent verdict over Chrome technology The Cheap InvestorApril 18, 2023April 18, 20230 By Blake Brittain (Reuters) – Alphabet’s Google LLC on Tuesday convinced a U.S. appeals court to cancel three anti-malware patents…
BusinessEconomy ECB’s Lane backs May rate hike with size depending on data The Cheap InvestorApril 18, 2023April 18, 20230 FRANKFURT (Reuters) -The European Central Bank’s (ECB) chief economist on Tuesday backed a further interest rate increase at the ECB’s…
BusinessHealth J&J issues cautious 2023 forecast, shares fall The Cheap InvestorApril 18, 2023April 18, 20230 By Bhanvi Satija and Manas Mishra (Reuters) – Johnson & Johnson on Tuesday cautioned investors over the lingering impact of…
BusinessEconomy EU plans to prevent taxpayer cash being used to save failing banks The Cheap InvestorApril 18, 2023April 18, 20230 By Huw Jones (Reuters) -The European Union on Tuesday proposed making it harder for states to pour billions of euros…
BusinessEurope AstraZeneca confident new COVID antibody protects against known variants The Cheap InvestorApril 18, 2023April 18, 20230 By Maggie Fick BARCELONA (Reuters) – AstraZeneca is confident that its new version of COVID-19 antibody treatment could protect immunocompromised…
BusinessEconomy Despite SVB collapse, FDIC on track to recoup insurance losses: Chair The Cheap InvestorApril 18, 2023April 18, 20230 (Reuters) – Despite the second- and third-largest bank failures in U.S. history last month, the U.S. Federal Deposit Insurance Corporation…
AsiaBusiness Once-dominant foreign auto brands pledge comeback in China The Cheap InvestorApril 18, 2023April 18, 20230 SHANGHAI (Reuters) -Global automakers, including Toyota and Volkswagen, took the stage at the Shanghai auto show on Tuesday with built-for-China…
BusinessCanada Lockheed Martin taps strong defense demand to beat results estimates The Cheap InvestorApril 18, 2023April 18, 20230 By Mike Stone and Shivansh Tiwary (Reuters) -U.S. weapons maker Lockheed Martin Corp’s first-quarter results surpassed Wall Street targets on…
BusinessCanada GSK bets $2 billion on Bellus cough drug to soothe pipeline fears The Cheap InvestorApril 18, 2023April 18, 20230 By Natalie Grover and Aby Jose Koilparambil (Reuters) -GSK plans to buy Canada-based drug developer Bellus Health Inc in an…
BusinessEconomy UK regulator probes Amazon’s planned purchase of iRobot The Cheap InvestorApril 18, 2023April 18, 20230 (Reuters) -Britain’s competition regulator said on Tuesday it has launched a “Phase 1” probe into Amazon.com Inc’s planned $1.7 billion…